Objective
Infectious diseases (ID) pose a continuous and serious threat to global health and economies. Reducing the impact of emerging infectious diseases (EID) and antimicrobial resistance (AMR) requires long-term, sustainable, international efforts. The European consortia COMBACTE and PREPARE have the joint ambition to establish a coordinated, permanent, pan-European infrastructure for clinical research on ID (ECRAID). The mission of ECRAID is to reduce the impact of ID on individual and population health by generating rigorous evidence to improve the diagnosis, prevention and treatment of IDs, and to better respond to ID threats. In ECRAID-Plan the coordinators and co-coordinators of PREPARE and COMBACTE, together with the (co-)coordinators of 12 other highly complementary networks and infrastructures, will develop a detailed Business Plan for ECRAID, which will serve: (i) as the guiding document in the implementation of ECRAID, (ii) to inform external stakeholders (network partners, industry, funders, policy makers, regulators, users) about ECRAID and (iii) to get commitment for sufficient start-up funding to commence operations in ECRAID, allowing for a smooth transition of activities from the current funding periods of PREPARE and COMBACTE. ECRAID-Plan will be completed within 24 months, involving extensive consultation of a multisectoral stakeholder platform. ECRAID-Plan will focus on the development of the key components of the business plan, including (i) an internal analysis of strengths and weaknesses, (ii) an external analysis of relevant stakeholders and their needs, developments in the scientific, policy and other domains and opportunities and threats, (iii) the service offering and business model, (iv) operational processes and policies, (v) governance structure and (vi) an investment plan and operational budget. Cross-cutting themes include reconciliation of AMR and EID research, data sharing and interoperabilty of networks.
Field of science
- /medical and health sciences/basic medicine/pharmacology and pharmacy/drug resistance/antibiotic resistance
- /social sciences/economics and business
Call for proposal
H2020-SC1-2018-Single-Stage-RTD
See other projects for this call
Funding Scheme
CSA - Coordination and support actionCoordinator
3584 CX Utrecht
Netherlands
Participants (12)
2000 Antwerpen
75013 Paris
35127 Padova
901 87 Umea
13284 Marseille
2800 Kgs Lyngby
3015 GD Rotterdam
13353 Berlin
1000 Brussel
00149 Roma
OX1 2JD Oxford
1105AZ Amsterdam
